Multiple sclerosis trials in Mexico
5 of 6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
- Where
- Culiacán, Mexico City
- Age
- 10 years to 17 years
- People
- 12 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07161258 · EU 2024-519800-28-00 - Phase 3Taking peopleEfficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
- Where
- Mexico City
- Age
- 40 years to 70 years
- People
- 400 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06846281 · EU 2023-509275-17-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Where
- Benito Juárez, Chihuahua City, Mexico City, San Luis Potosí City
- Age
- 18 years to 65 years
- People
- 1,275 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07225504 - Phase 3Taking peopleStudy to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Where
- Mexico City
- Age
- 10 years to 17 years
- People
- 194 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06408259 · EU 2022-501332-42-00 - Phase 2Enrolling by invitationImproving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration
- Where
- Mexico City
- Age
- 18 years to 65 years
- People
- 80
- Run by
- Universidad Nacional Autonoma de Mexico
See details and how to joinNCT06223074